Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
出版年份 2021 全文链接
标题
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
作者
关键词
-
出版物
BMC INFECTIOUS DISEASES
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-28
DOI
10.1186/s12879-021-06164-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2
- (2020) Philippine Eloy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SARS-CoV-2 detection, viral load and infectivity over the course of an infection
- (2020) Kieran A. Walsh et al. JOURNAL OF INFECTION
- Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19
- (2020) Aleksandra Klimczak World Journal of Stem Cells
- Anti-Ebola therapy for patients with Ebola virus disease: a systematic review
- (2019) James S. Lee et al. BMC INFECTIOUS DISEASES
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality
- (2016) Xiuming Xi et al. BMC INFECTIOUS DISEASES
- Dose regimen of favipiravir for Ebola virus disease
- (2015) France Mentré et al. LANCET INFECTIOUS DISEASES
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
- (2009) Yousuke Furuta et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started